Promore Pharma investor relations material

Promore Pharma AB, a biopharmaceutical company, develops therapeutic peptides for the bio-active wound care market in Sweden and internationally. The company offers Promogran Prisma, a collagen-based matrix; RESTORE collagen matrix, a synthetic medical device; PromoFoam matrix, a calcium alginate wound dressing; PAH250 Woundhance, a pharmaceutical agent used in the treatment of chronic wounds; and CytoMend, a resorbable extracellular matrix. It is also developing Platelet Rich Plasma (PRP), which has new functions for patients with chronic wounds; and Aktipak, which is indicated for treating acute deep wounds in conjunction with surgery/suture and debridement/wound bed preparation.